Allogene Therapeutics Inc (ALLO)
3.075
-0.12
(-3.61%)
USD |
NASDAQ |
Nov 08, 16:00
3.075
0.00 (0.00%)
After-Hours: 17:13
Allogene Therapeutics Revenue (Annual): 0.095M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 0.095M |
December 31, 2022 | 0.156M |
Date | Value |
---|---|
December 31, 2021 | 114.09M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.095M
Minimum
2023
114.09M
Maximum
2021
38.11M
Average
0.156M
Median
2022
Revenue (Annual) Benchmarks
ICU Medical Inc | 2.259B |
OPKO Health Inc | 863.50M |
Envista Holdings Corp | 2.566B |
Outset Medical Inc | 130.38M |
AIM ImmunoTech Inc | 0.202M |